2013 annual financial data

Celldex Therapeutics 2013 Net margin

Celldex Therapeutics 2013 net margin with verified reported values.

Direct answer

Net margin was -1,983.7%.

Operating income was -81,442,000 USD and net income was -81,550,000 USD.
Operating cash flow was -67,669,000 USD.

Get free Celldex Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4,111,000 USD
Operating income
-81,442,000 USD
Net income
-81,550,000 USD
Operating cash flow
-67,669,000 USD